Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1989-08-08
2000-01-25
Geist, Gary
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514561, 560124, A61K 31215
Patent
active
060179570
ABSTRACT:
A method is disclosed for the treatment of neuropsychopharmacological disorders which are associated with or result from excessive activation of the N-methyl-D-aspartate receptor complex, which method comprises administering an effective neuropsychopharmacological disorder-treating amount of a compound possessing partial agonist properties for the strychnine insensitive glycine modulatory sites of N-methyl-D-aspartate receptors. Exemplary of partial agonists which are useful in the method of the invention are 1-aminocyclopropanecarboxylic acid, and associated derivates thereof. Novel injectable pharmaceutical compositions are also disclosed.
REFERENCES:
patent: 4491589 (1985-01-01), Dell et al.
patent: 4554017 (1985-11-01), Schroder et al.
patent: 4746653 (1988-05-01), Hutchison et al.
patent: 5086072 (1992-02-01), Trullus et al.
Bonta et al, Brit. J. Pharmacol. 43(3) 514-35, 1971.
Singh et al Proc. Natl. Acad. Sci. USA 87, 347-351, 1990.
Nadler et al, European Journal of Pharmacology, vol. 157, pp. 115-116, 1988.
Marvizon et al, J Neurochem, vol. 52, p. 992-994, 1989.
Robinson et al, FASEB J, vol. 1, pp. 446-455, 1987.
Faster et al, Nature, vol. 392, pp. 395-396, 1987.
P. Skolnick et al, Life Sciences, vol. 45, No. 18 (1989), pp. 1647-1655.
R. Trullas et al, Pharm.Bioch. & Beh., vol. 34, (1989), pp. 313-316.
D. W. Choi, Neuron, vol. 1, Oct. 1988, pp. 623-934.
J. T. Winslow et al, Europ. J. of Pharm., vol. 190 (1990), pp. 11-21.
J. D. Leander et al, Brain Research, vol. 448 (1988), pp. 115-120.
J. Lehman et al, Drug Discov. Div., Ciba-Geigy Corp., pp. 31-40.
C. Cotman et al, J. of NIH Res., vol. 1, pp. 65-74 (1989).
J. W. Olney, Biol. Psychiatry, vol. 26, (1989), pp. 505-525.
Lewin Anita
Marvizon Juan-Carlos
Monn James
Rice Kenner
Skolnick Phil
Geist Gary
The United States of America as represented by the Department of
LandOfFree
Partial agonists of the strychnine insensitive glycine modulator does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Partial agonists of the strychnine insensitive glycine modulator, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Partial agonists of the strychnine insensitive glycine modulator will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2316319